Horse umbilical cord stem cell storage service
12 September, 2006 by External Press Release AuthorAnimal health care company Vet Biotechnology has launched a collection service for equine umbilical cord stem cells from the afterbirth of newborn thoroughbred foals.
Clinuvel sells EpiPharm, announces EPP trail
12 September, 2006 by External Press Release AuthorClinuvel Pharmaceuticals has entered into a heads of agreement with Genepharm Australasia for the sale of Clinuvel's EpiPharm range of pharmaceutical products.
Life science stocks decline in last quarter
01 September, 2006 by External Press Release AuthorThe value of the Australian life science sector declined 3.5 per cent during the fourth quarter, ending 30 June 2006, according to the latest BioForum report from PricewaterhouseCoopers (PwC).
Rice gene machine rolls on
21 July, 2006 by Kate McDonaldThe big names in the world of rice genomics will gather in Adelaide this August for the International Society of Plant Molecular Biology (ISPMB) congress. Kate McDonald spoke to CSIRO Plant Industry's Dr Narayana Upadhyaya about progress in his field, rice functional genomics.
Polymer proves a potent mix for the old bung knee
21 July, 2006 by Kate McDonaldCSIRO has come up with a new technique for repairing knee cartilage by combining chondrocytes with a biodegradable polymer.
The agricultural holy grail
21 July, 2006 by Graeme O'NeillSequencing of the cattle genome is nearly complete and will herald a revolution in breed improvement.
Unlocking the potential of agricultural biotechnology
20 July, 2006 by Graeme O'NeillThe Agricultural Biotechnology International Conference (ABIC) is being held in Melbourne this year, bringing with it such names as Alan Colman, Jennifer Thomson and Robert Wall. With Australia's economy still so reliant on the land, Graeme O'Neill takes a look at what our neighbours across the pond can teach us about harnessing the power of biotechnology in agriculture.
Hunting the source of renewable oocytes
20 July, 2006 by External Press Release AuthorFemale mammals may continue to proudce eggs throughout puberty and adulthood.
Positive phase I data for Novogen's bowel disease drug
02 March, 2006 by Ruth BeranA recently completed phase I clinical trial of biopharmaceutical company Novogen's (ASX:NRT) anti-inflammatory compound NV-52 has shown rapid absorption indicating its potential as an oral therapy, according to the company.
Zenyth in-licenses antibody patents from Ludwig
02 March, 2006 by Ruth BeranMelbourne's Zenyth Therapeutics (ASX:ZTL), formerly Amrad, has in-licensed patents from the Ludwig Institute for Cancer Research for antibodies that target a key part of the inflammatory process.
'Frustrating' delays for Chemeq's regulatory approval
02 March, 2006 by Ruth BeranRegulatory approval for Chemeq's (ASX:CMQ) polymeric antimicrobial CHEMEQ has been delayed in some jurisdictions, pushing expected registrations out in some cases to 2007.
CathRx files for cardiac catheters CE Mark
01 March, 2006 by Ruth BeranCathRx (ASX:CXD) has taken the first step in the CE Mark approval process for its cardiac diagnostic catheters.
Clinuvel begins controlled-release implant trial
01 March, 2006 by Ruth BeranMelbourne's Clinuvel Pharmaceuticals (ASX:CUV), formerly Epitan, has begun a trial in Adelaide of its lead drug CUV1647 in a controlled-release pellet form.
Peplin's phase IIa 'sun spot' trial positive, second BCC trial enrolment complete
28 February, 2006 by Helen SchullerPeplin (ASX:PEP) has reported preliminary results of its US-based phase IIa dose escalation clinical trial to establish the maximum tolerated dose of PEP005 in actinic keratosis (AK), also known as solar keratosis, a skin condition which can develop into skin cancer.
Rockeby to supply avian flu tests in Turkey, aims to raise $1.73m
28 February, 2006 by Ruth BeranSingapore-based Rockeby Biomed (ASX:RBY) has signed an exclusive deal to supply its avian flu kits to the Turkish Poultry Industry, an organisation which represents 90 per cent of the poultry industry in Turkey.
